SCHEMBL6169007

SCHEMBL6169007

CCc1noc(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.50
PTGS2 P35354 2/20 0.50
PTPN1 P18031 1/20 0.50
DHFR P00374 1/20 0.45
HEXA P06865 1/20 0.45
HEXB P07686 1/20 0.45
BRD4 O60885 2/20 0.43
BRD2 P25440 1/20 0.43
ALDH1A1 P00352 5/20 0.42
HPGD P15428 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDO2 P48775 1/20 0.41
MLYCD O95822 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
IP6K1 Q92551 2/20 0.38
GCGR P47871 1/20 0.38
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfamide SCHEMBL4639248 0.91 PTPN1 (0.46) PTGS1PTGS2PTPN1DHFRHEXA
SCHEMBL6169852 0.91 MAPK10 (0.46) PTGS1PTGS2PTPN1DHFRHEXA
SCHEMBL6167853 0.89 PTGS2 (0.43) PTGS1PTGS2PTPN1DHFRHEXA
SCHEMBL6168431 0.87 PTGS2 (0.54) PTGS2
SCHEMBL6168613 0.84 PTGS2 (0.57) PTGS1PTGS2
SCHEMBL213407 0.84 PTGS2 (0.57) PTGS1PTGS2
SCHEMBL28765430 0.82 CHUK (0.44) PTGS1PTGS2PTPN1ALDH1A1HPGD
SCHEMBL10920153 0.80 PTGS1 (0.49) PTGS1PTGS2DHFRHEXAHEXB
SCHEMBL12088082 0.80 DHFR (0.44) PTGS1PTGS2PTPN1DHFRHEXA
SCHEMBL6167859 0.78 NPC1 (0.38) PTGS1PTGS2PTPN1DHFRHEXA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528059-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle LLC (US) 2005-05-04 EP disclosed
EP-0809636-B1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2002-09-04 EP disclosed
EP-1223167-A2 Substituted isoxazoles for the treatment of inflammation G.D. Searle & Co. (US) 2002-07-17 EP disclosed
US-5859257-A ANTIINFLAMMATORY, ANTIARTHRITIC AGENTS G. D. SEARLE & CO. (US) 1999-01-12 US disclosed
EP-0809636-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-12-03 EP disclosed
WO-1996025405-A1 SUBSTITUTED ISOXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-08-22 WO disclosed